- Pumps and syringes most common delivery method
- U.S. Food and Drug Administration and Health Canada approve new insulin pump
- FDA also OKs glucose monitor app
Last year, the insulin-delivery services market reached $10.4 billion, according to a report from Axis Research Mind.
The market is divided into two segments – invasive devices and non-invasive devices. The most common insulin delivery devices are pumps and syringes, dominating half the market, a position that is expected to continue.